SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.470.0%Dec 9 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (508)2/14/2000 9:43:00 AM
From: scaram(o)uche  Read Replies (2) of 1475
 
$8/share, they've done it again. Sure are making Carson Group look good.....

Monday February 14, 9:15 am Eastern Time

Company Press Release

SOURCE: BioTransplant Incorporated

BioTransplant Incorporated Completes $9.7 Million
Private Placement

CHARLESTOWN, Mass., Feb. 14 /PRNewswire/ -- BioTransplant Incorporated (Nasdaq: BTRN - news) today announced
that it has completed a private placement of approximately 1.2 million shares of Common Stock to selected institutional and
accredited investors, for aggregate proceeds of approximately $9.7 million or $8 per share. Evolution Capital, a subsidiary of
the Carson Group, acted as placement agent for this transaction. The Common Stock sold has not been registered under the
Securities Act of 1933 and may not be offered or sold in the United States, except pursuant to an applicable exemption from
the Securities Act regulation requirements.

The Company intends to use the proceeds from the sale of its Common Stock to further advance the clinical development of its
AlloMune(TM) family of product candidates and to provide it with working capital for other general corporate purposes.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Common Stock. This press release
is being issued pursuant to and in accordance with Rule 135c under the Securities Act.

SOURCE: BioTransplant Incorporated
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News